Drug intelligence / Profile preview

killed escherichia coli k12

Development stage
Preclinical
Lead developer
Janssen Pharmaceutical
Modality
Vaccines & Immunotherapeutics
Administration
Oral, Intranasal
01

Overview

Killed *Escherichia coli* K-12 refers to an inactivated preparation of the *Escherichia coli* K-12 strain, a widely used laboratory bacterium. This preparation is primarily investigated in research settings, particularly for its potential as a vaccine candidate. When used as a vaccine, its mechanism of action involves presenting bacterial antigens to the host's immune system, thereby stimulating a humoral and/or cellular immune response to protect against specific pathogens or conditions. Studies have explored its use in developing vaccines against influenza and extraintestinal pathogenic *E. coli* (ExPEC) infections. The use of heat-killed *E. coli* K12 for oral administration has been proven safe in clinical trials.

Beyond the preview

Go deeper on killed escherichia coli k12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on killed escherichia coli k12.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call